The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis

MAP kinases are some of the cascades that are specialized in the cell's response to external stimuli. Their impaired functioning can be observed during the course of psoriatic arthritis. Currently, the best-known class of biological drugs is the inhibitors of the proinflammatory cytokine TNF-α,...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Current pharmaceutical biotechnology Ročník 24; číslo 2; s. 330
Hlavní autori:	Krawczyk, Agata, Strzałka-Mrozik, Barbara, Juszczyk, Karol, Kimsa-Dudek, Magdalena, Wcisło-Dziadecka, Dominika, Gola, Joanna
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands 01.01.2023
Predmet:	Adalimumab - pharmacology Adalimumab - therapeutic use Antirheumatic Agents - adverse effects Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - genetics Cytokines Humans MAP Kinase Kinase 2 Tumor Necrosis Factor-alpha - genetics MAPK2 psoriatic arthritis MAPK adalimumab gene expression anti-TNF
ISSN:	1873-4316, 1873-4316
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!